Market Size of Amniocentesis Needle Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.40 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Amniocentesis Needle Market Analysis
The market for amniocentesis is expected to grow steadily over the forecast period. Certain factors that are responsible for the growth of this market are the growing median age of first-time motherhood, the increasing burden of the congenital diseases, and the high reliability of people on amniocentesis.
Amniocentesis is almost 99.4% accurate and this test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward's syndrome, Tay-Sachs disease, Huntington's disease, sickle cell disease, and cystic fibrosis. It can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, its adoption is good across several healthcare facilities, therefore the market is expected to expand over the forecast period.
Amniocentesis Needle Industry Segmentation
Amniocentesis is a procedure that is used for the diagnosis of fetal defects in the second trimester of pregnancy. A sample from the amniotic fluid, surrounding the fetus in the womb, is collected through a pregnant woman's abdomen using a needle and syringe.
| By Type | |
| 100 to 150 mm Needles | |
| Larger Than 150 mm Needles | |
| Smaller Than 100 mm Needles |
| By Procedure | |
| Amniocentesis Procedures | |
| Amnioreduction Procedures | |
| Fetal Blood Transfusion Procedures | |
| Amnioinfusion Procedures | |
| Cordocentesis Procedures |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Amniocentesis Needle Market Size Summary
The amniocentesis needle market is poised for steady growth, driven by factors such as the increasing median age of first-time motherhood and the rising prevalence of congenital diseases. The high accuracy of amniocentesis, which can detect genetic and chromosomal abnormalities with significant reliability, has led to its widespread adoption across healthcare facilities. This procedure is crucial for identifying genetic disorders like Down syndrome and cystic fibrosis, contributing to its growing acceptance. Despite concerns about risks such as early abortion, advancements in needle technology and a focus on patient safety are expected to mitigate these issues, further supporting market expansion. The global increase in birth rates, particularly in countries like India, is also enhancing the demand for amniocentesis procedures, indicating a positive outlook for the market.
Regionally, North America and Europe dominate the amniocentesis needle market, with North America expected to maintain its leading position. The region benefits from a developed healthcare system and government initiatives that promote the use of advanced medical technologies. The concern over genetic disorders among the North American population is also fueling demand. The market is moderately competitive, with a significant presence of local companies, especially in countries like China and India, which intensifies competition among local suppliers. While global companies are present, the competition among major players is less intense compared to that among local firms. Key players in the market include Becton Dickinson and Company, The Cooper Companies, Inc., and Medtronic Plc, among others.
Amniocentesis Needle Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 High Reliability of Amniocentesis
-
1.2.2 Growing Median Age of First-Time Motherhood
-
1.2.3 Increasing Burden of Congenital Disorders
-
-
1.3 Market Restraints
-
1.3.1 Availability of Alternate Methods
-
1.3.2 Lack of Skilled Professionals
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Type
-
2.1.1 100 to 150 mm Needles
-
2.1.2 Larger Than 150 mm Needles
-
2.1.3 Smaller Than 100 mm Needles
-
-
2.2 By Procedure
-
2.2.1 Amniocentesis Procedures
-
2.2.2 Amnioreduction Procedures
-
2.2.3 Fetal Blood Transfusion Procedures
-
2.2.4 Amnioinfusion Procedures
-
2.2.5 Cordocentesis Procedures
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Amniocentesis Needle Market Size FAQs
What is the current Amniocentesis Needle Market size?
The Amniocentesis Needle Market is projected to register a CAGR of 5.40% during the forecast period (2024-2029)
Who are the key players in Amniocentesis Needle Market?
Becton Dickinson and Company, The Cooper Companies, Inc., Cook Medical Incorporated, RI.MOS. srl and Medtronic Plc are the major companies operating in the Amniocentesis Needle Market.
